Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/17919
Title: An official European Respiratory Society statement on physical activity in COPD
Authors: Watz, Henrik
Pitta, Fabio
Rochester, Carolyn L.
Garcia-Aymerich, Judith
ZuWallack, Richard
Troosters, Thierry
Vaes, Anouk W.
Puhan, Milo A.
Jehn, Melissa
Polkey, Michael I.
Vogiatzis, Ioannis
Clini, Enrico M.
Toth, Michael
Gimeno-Santos, Elena
Waschki, Benjamin
Esteban, Cristobal
Hayot, Maurice
Casaburi, Richard
Porszasz, Janos
McAuley, Edward
Singh, Sally J.
Langer, Daniel
Wouters, Emiel F.M.
Magnussen, Helgo
SPRUIT, Martijn A. 
Issue Date: 2014
Source: EUROPEAN RESPIRATORY JOURNAL, 44 (6), p. 1521-1537
Abstract: This European Respiratory Society (ERS) statement provides a comprehensive overview on physical activity in patients with chronic obstructive pulmonary disease (COPD). A multidisciplinary Task Force of experts representing the ERS Scientific Group 01.02 “Rehabilitation and Chronic Care” determined the overall scope of this statement through consensus. Focused literature reviews were conducted in key topic areas and the final content of this Statement was agreed upon by all members. The current knowledge regarding physical activity in COPD is presented, including the definition of physical activity, the consequences of physical inactivity on lung function decline and COPD incidence, physical activity assessment, prevalence of physical inactivity in COPD, clinical correlates of physical activity, effects of physical inactivity on hospitalisations and mortality, and treatment strategies to improve physical activity in patients with COPD. This Task Force identified multiple major areas of research that need to be addressed further in the coming years. These include, but are not limited to, the disease-modifying potential of increased physical activity, and to further understand how improvements in exercise capacity, dyspnoea and self-efficacy following interventions may translate into increased physical activity. The Task Force recommends that this ERS statement should be reviewed periodically (e.g. every 5–8 years).
Notes: Correspondence: Henrik Watz, Pulmonary Research Institute at LungenClinic Grosshansdorf, Woehrendamm 80, D-22927 Grosshansdorf, Germany. E-mail: h.watz@pulmoresearch.de.
Document URI: http://hdl.handle.net/1942/17919
Link to publication/dataset: http://erj.ersjournals.com/content/44/6/1521.long
ISSN: 0903-1936
e-ISSN: 1399-3003
DOI: 10.1183/09031936.00046814
ISI #: 000347267500015
Rights: Copyright © ERS 2014.
Category: A1
Type: Journal Contribution
Validations: ecoom 2016
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
1521.full.pdfPublished version426.62 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

230
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

342
checked on Apr 22, 2024

Page view(s)

108
checked on Sep 7, 2022

Download(s)

162
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.